Medicare spent $2.1B on discarded drugs in 2 years, study shows
(By Katie Adams for Becker’s Hospital Review) More than $2.1 billion of Medicare Part B’s spending from 2017 to 2019 went
Read More
Author: Eileen Cook
Point32Health challenges Aduhelm, threatens coverage for 1.1M members
(By Nick Moran for Becker’s Hospital Review) Point32Health may not cover Biogen’s new Alzheimer’s treatment, Aduhelm, for its commercial members unless
Read MoreThe Ensuring Patient Access to Critical Breakthrough Products Act
The bipartisan bill, The Ensuring Patient Access to Critical Breakthrough Products Act, would require Medicare to cover all breakthrough devices
Read MoreState insurance marketplaces offered $20M in grants from CMS
(By Nick Moran for Becker’s Hospital Review) State-based insurance marketplaces are now eligible for $20 million in new grant money
Read MoreA crucial, overlooked question on the new Alzheimer’s drug: When should patients stop taking it?
(By Megan Molteni for STAT) For families and physicians grappling with the historic approval this month of the controversial Alzheimer’s
Read MoreBiden’s Broader Vision For Medicaid Could Include Inmates, Immigrants, New Mothers
(By Noam N. Levey and Phil Galewitz for NPR) The Biden administration is quietly engineering a series of expansions to
Read More5 BCBS plans back pharmacy startup
(By Nick Moran for Becker’s Hospital Review) Five Blue Cross Blue Shield plans are funding and collaborating with Evio, a
Read MorePrioritize your mental health with help from VA
(Source -blogs.va.gov) Like many Veterans, you may put your family, your career and supporting others ahead of taking care of
Read MoreMedicaid enrollment reaches all-time high during pandemic
(By Lauren Jensik for Becker’s Hospital Review) Medicaid enrollment reached an all-time high of 74 million members during the pandemic, a
Read MoreDrug-resistant bacteria pose a growing threat. Can new antibiotics be developed fast enough to combat them?
(By Ed Silverman for STAT) In 2016, a landmark report was issued on the global problem of antimicrobial resistance. The paper,
Read More